
Karolinska Development AB (publ)
KDEVFOTCHealthcare
$0.26
+$0.00(+0.00%)
Market Cap$68850739
P/E Ratio—
52W High$0.61328
52W Low$0.2576
Karolinska Development AB (publ)(KDEVF)· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · KDEVF · 截至 2026-06-09
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $5.39M | ($87.42M) | $160.70M | ($202.43M) | $347.94M |
| Depreciation & Amort. | $0.80M | $0.69M | $0.69M | $0.69M | $0.70M |
| Stock-Based Comp. | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Change in Working Capital | ($1.00M) | ($1.25M) | $44.62M | ($3.72M) | $32.56M |
| Net Cash from Operations | ($25.02M) | ($32.53M) | $16.70M | ($33.20M) | ($7.41M) |
| Investing Activities | |||||
| Capital Expenditure | $98.59M | $0.00M | ($6.42M) | ($62.70M) | $46.96M |
| Purchases of Investments | ($98.59M) | ($10.00M) | ($50.01M) | ($39.15M) | ($46.96M) |
| Sales of Investments | $60.34M | $0.00M | $6.42M | $101.85M | $69.14M |
| Net Cash from Investing | ($19.98M) | ($113.81M) | ($49.46M) | $57.61M | $57.24M |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | ($0.80M) | $235.02M | ($0.71M) | ($0.67M) | ($13.54M) |
| Free Cash Flow | |||||
| Free Cash Flow | $73.57M | ($32.53M) | $10.28M | ($95.90M) | $39.55M |
| FCF Margin %(computed) | — | — | 473.69% | — | — |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · SEK · M
深入了解Karolinska Development AB (publ)
关于Karolinska Development AB (publ)(KDEVF)现金流量表
Karolinska Development AB (publ) 2023财年经营活动现金流($0.03B),自由现金流$0.07B(FCF利润率2620.88%),资本支出$0.10B。
常见问题
KDEVF · 4 问Karolinska Development AB (publ) 2023财年自由现金流$0.07B,同比up326.1%。
KDEVF free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09